Tuesday’s election results will set the course and define the final two years of President Trump’s presidency. Republicans close to the White House say he will not go quietly into the night as a lame duck. A strategist informed the Washington Examiner that the GOP will still revolve around him even once the 2028 race begins in earnest. This stance matters because the party faces a split between those loyal to Trump and those seeking their own path forward.
Before voters head to the polls, the administration secured a major win on drug costs for workers. A rule finalized by the Labor Department on October 29 mandates that pharmacy benefit managers reveal hidden fees to large employers. Stating that PBMs have operated in the shadows, pocketing hidden fees while workers and employers were left in the dark, Labor Secretary Keith Sonderling made the announcement. The new rule targets spread pricing, where a manager charges more for a drug than it pays the pharmacy. Employers can now audit these disclosures to find the real costs.
Final polling shows a deep divide on who will control the Senate after Tuesday. The New York Times/Siena Polls show Democrats leading in all battleground states, including Texas where James Talarico leads 50 to 43 percent. Other firms like Trafalgar and Emerson show much tighter races with candidates separated by less than one percent. According to reports, Democrats lead the generic ballot by an unprecedented 14 percent. However, some analysts question if these polls oversample Democrats or use the wrong voter groups.
RedState noted that 46 percent of respondents in the Atlas poll named “safeguarding democracy” as one of “the country’s greatest challenges facing the United States today.” Critics note that only Democrats say this, suggesting the poll may not reflect the true mood of likely voters. The discrepancy between these polls makes the outcome of the Senate races harder to predict with certainty.
This shift could lead to a reckoning within the party as members jockey for position in the 2028 primary.
The administration estimates the new drug transparency rule could save up to $22 billion in lower prescription spending over a decade. Utah Auditor Tina Cannon welcomed the change but urged the Department of Labor to extend these requirements to third-party administrators. She holds that state financial officers will leverage this data to demand heightened accountability for taxpayer funds. The real test will be whether employers use these new reports to negotiate better deals with their benefit managers.
As the election results arrive, the question remains how the party handles the transition to a potentially divided Congress. The administration has until January 3 to push through reforms before Democrats might take charge of the House. The outcome of Tuesday will determine if the final two years are defined by unity or by a fight for the party’s future direction. Even when the 2028 race truly starts, the GOP will still revolve around him.
